View in EDS HTML Full Text PDF Full Text

Harnessing IDO inhibitors to optimize cancer immunotherapy.

Saved in:
Bibliographic Details
Title: Harnessing IDO inhibitors to optimize cancer immunotherapy.
Authors: Rab SO; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia., Jaafar HK; Department of Applied Sciences, University of Technology, Baghdad, Iraq., Jabir MS; Department of Applied Sciences, University of Technology, Baghdad, Iraq., Malathi H; Department of Biotechnology and Genetics, School of Sciences, JAIN (deemed to be University), Bangalore, Karnataka, India., Devi S; Chandigarh Pharmacy College, Chandigarh Group of Colleges, Mohali-140307, Jhanjheri, Punjab, India., Pramanik A; School of Applied and Life Sciences, Division of Research and Innovation, Uttaranchal University, Dehradun, Uttarakhand, India., Al-Hetty HRAK; Department of Biology, College of Education for Pure Sciences, University of Anbar, Ramadi, Anbar, 31001, Iraq. hussin.riyadh@uoanbar.edu.iq., Alnajar MJ; Department of Pharmacy, Al-Nisour University College, Nisour Seq. Karkh, Baghdad, Iraq., Jawad SF; Department of Pharmacy, Al-Mustaqbal University College, Hillah, Babylon, 51001, Iraq., Mustafa YF; Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, 41001, Iraq.
Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2025 Dec; Vol. 398 (12), pp. 16797-16815. Date of Electronic Publication: 2025 Jul 17.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-1912
DOI:10.1007/s00210-025-04445-9